A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years
- 1 February 2007
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 90 (2) , 171-180
- https://doi.org/10.1016/j.ymgme.2006.08.007
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The first 5years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis IExpert Opinion on Pharmacotherapy, 2005
- Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase)The Journal of Pediatrics, 2004
- Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis IThe Lancet, 2003
- The eye as a window to inborn errors of metabolismJournal of Inherited Metabolic Disease, 2003
- Disordered breathing during sleep in patients with mucopolysaccharidosesPublished by Elsevier ,2001
- Enzyme-Replacement Therapy in Mucopolysaccharidosis INew England Journal of Medicine, 2001
- Magnetic resonance imaging in the diagnosis of the cranio-cervical manifestations of the mucopolysaccharidosesMagnetic Resonance Imaging, 1987